Results 121 to 130 of about 4,653 (155)
Network pharmacology combined with ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry method to explore the mechanism of Shizhi Fang in treating uric acid nephropathy mice. [PDF]
J Tradit Chin MedFeng Y +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 2008
*Febuxostat is an orally administered, non-purine, selective inhibitor of xanthine oxidase approved for the management of chronic hyperuricaemia in patients with gout. *In a randomized, double-blind, dose-ranging study in patients with gout and hyperuricaemia, significantly more recipients of febuxostat 40-120 mg/day than placebo had serum urate levels
Philip I, Hair +2 more
openaire +4 more sources
*Febuxostat is an orally administered, non-purine, selective inhibitor of xanthine oxidase approved for the management of chronic hyperuricaemia in patients with gout. *In a randomized, double-blind, dose-ranging study in patients with gout and hyperuricaemia, significantly more recipients of febuxostat 40-120 mg/day than placebo had serum urate levels
Philip I, Hair +2 more
openaire +4 more sources
Reactions Weekly, 2016
Mit Febuxostat steht eine Alternative zu Allopurinol zur Verfügung. Seine Wirkung auf die Harnsäurespiegel ist gut dokumentiert; ob das Mittel in Bezug auf die praktisch relevanten Gichtsymptome ebenbürtig ist oder besser abschneidet, ist bisher nicht klar.
+5 more sources
Mit Febuxostat steht eine Alternative zu Allopurinol zur Verfügung. Seine Wirkung auf die Harnsäurespiegel ist gut dokumentiert; ob das Mittel in Bezug auf die praktisch relevanten Gichtsymptome ebenbürtig ist oder besser abschneidet, ist bisher nicht klar.
+5 more sources
Drug and Therapeutics Bulletin, 2010
Around 1.4% of the UK population have gout, the prevalence of which increases with age to around 3% in women and 7% in men aged over 75 years.1–3 Acute gout is intensely painful and can reduce patients’ quality of life.2,3 It occurs when the serum uric acid concentration (SUA) rises (hyperuricaemia) and persists above the solubility threshold of ...
openaire +2 more sources
Around 1.4% of the UK population have gout, the prevalence of which increases with age to around 3% in women and 7% in men aged over 75 years.1–3 Acute gout is intensely painful and can reduce patients’ quality of life.2,3 It occurs when the serum uric acid concentration (SUA) rises (hyperuricaemia) and persists above the solubility threshold of ...
openaire +2 more sources
Hospital Pharmacy, 2009
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Dennis J. Cada +2 more
openaire +1 more source
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Dennis J. Cada +2 more
openaire +1 more source
DMW - Deutsche Medizinische Wochenschrift, 2011
K, Wittköpper, J, Emons, A, El-Armouche
openaire +3 more sources
K, Wittköpper, J, Emons, A, El-Armouche
openaire +3 more sources